Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
75 hedge funds and large institutions have $22.7M invested in Spectrum Pharmaceuticals Inc in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 25 reducing their positions, and 26 closing their positions.
52% more call options, than puts
Call options by funds: $351K | Put options by funds: $231K
13% less funds holding
Funds holding: 86 → 75 (-11)
28% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 25
30% less capital invested
Capital invested by funds: $32.3M → $22.7M (-$9.61M)
42% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.05M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$704K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$626K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$584K |
| 5 |
CCM
CAAS Capital Management
New York
|
+$280K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$4.13M |
| 2 |
Millennium Management
New York
|
-$1.11M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$742K |
| 4 |
BlackRock
New York
|
-$648K |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$425K |
SPPI Hedge Fund Activity: Q3 2022 in Review
75 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2022, worth a combined $22.7M — down 30% from $32.3M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of SPPI and 15 opened new positions — a net loss of 11 holders — while 25 trimmed existing stakes and 18 added.
The largest buyer was Acadian Asset Management, adding an estimated $1.05M. The largest seller was D.E. Shaw & Co, cutting an estimated $4.13M.
- 75 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2022, down from 86 in Q2 2022.
- Funds reported $22.7M of Spectrum Pharmaceuticals Inc stock for Q3 2022, down 30% quarter-over-quarter.
- 15 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2022 and 26 closed out, a net change of -11 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q3 2022 was Acadian Asset Management, an estimated $1.05M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q3 2022 was D.E. Shaw & Co, an estimated $4.13M sold.
Based on aggregated 13F filings for Q3 2022.